Skip to main content

ETHNOS_APP

Home • Search • Journals • List 0

Yukteshwar Sookrajh

Biographic Data

ID7730058
NAMEYukteshwar Sookrajh
GIVEN NAMESYukteshwar
FAMILY NAMESookrajh
SIGNATURESOOKRAJH Y
AFFILIATIONSeThekwini Municipality
ORCID0000-0001-9029-5153
VERIFIEDYes
TOTAL WORKS7
TOTAL CITATIONS0
AUTHOR COUNT7
EDITOR COUNT0
FIRST PUBLICATION YEAR2021
LATEST PUBLICATION YEAR2026
H-INDEX0
  • Trends in advanced HIV disease, treatment interruption, and viraemia in KwaZulu-Natal, South Africa

    Open Access•Sanele S Mbeje, Lilishia Gounder et al.•ARTICLE•PLOS Global Public Health•2026

    Advanced HIV disease (AHD), treatment interruption and viraemia remain key challenges to effectiveness of HIV programmes in South Africa. Understanding the trends of these measures and their variation across geographic regions can inform more targeted and responsive interventions. We conducted a retrospective cohort study using routine, de-identified data from TIER.Net, a national HIV electronic register. We curated data from 116 primary care cli…

  • Quality assessment of data for decentralised antiretroviral therapy referrals and laboratory results in the South African national electronic HIV management register Tier.Net

    Open Access•Lisanthini Naidu, Johan van der Molen et al.•ARTICLE•PLOS Global Public Health•2026

    Three Interlinked Electronic Register (TIER.Net) is South Africa’s national electronic HIV patient database, used to monitor antiretroviral therapy (ART) delivery and laboratory results. However, few published evaluations have quantified TIER.Net data quality relative to national sources. We aimed to evaluate how well decentralised ART referral and laboratory result data are captured in TIER.Net. We conducted a retrospective analysis comparing TI…

  • Point-of-care HIV viral load testing in a community antiretroviral therapy delivery programme

    Open Access•Jienchi Dorward, Kwena Tlhaku et al.•ARTICLE•PLOS Global Public Health•2026

    Community antiretroviral therapy (ART) delivery programmes allow people with HIV (PWH) to collect treatment nearer to home instead of from clinics. However, delays in laboratory-based viral load (VL) testing can prevent timely community ART prescription renewals. We aimed to determine if clinic point-of-care VL testing could expedite community ART prescription renewals within the Centralised Chronic Medication Dispensing and Distribution programm…

  • Impact of increasing CD4 count threshold eligibility for antiretroviral therapy initiation on advanced HIV disease and tuberculosis prevalence and incidence in South Africa

    Open Access•Kwabena Asare, Lara Lewis et al.•ARTICLE•BMJ Global Health•2025

    INTRODUCTION: We investigated the impact of increasing CD4 count eligibility for antiretroviral therapy (ART) initiation on advanced HIV disease (AHD) and tuberculosis (TB) prevalence and incidence among people living with HIV (PLHIV) in South Africa. METHODS: We conducted an interrupted time series analysis with de-identified data of PLHIV aged ≥15 years initiating ART between April 2012 and February 2020 at 65 primary healthcare clinics in KwaZ…

  • Healthcare worker perspectives on adaptations to differentiated anti-retroviral therapy delivery during Covid-19 in South Africa

    Open Access•Kwena Tlhaku, Lindani Msimango et al.•ARTICLE•PLOS Global Public Health•2024

    During the COVID-19 pandemic, the South African Centralized Chronic Medicines Dispensing and Distribution (CCMDD) programme, adapted to include extended 12-month antiretroviral therapy (ART) prescriptions, 3-months ART refills and earlier eligibility criteria at 6-months after ART initiation. We aimed to explore the experiences of healthcare workers (HCWs) in implementing these adaptations, and to understand the overall impact of COVID-19 on CCMD…

  • Intimate Partner Violence and HIV Outcomes Among Women Living with HIV in Durban, South Africa

    Open Access•Sheila O Ojeaburu, Jienchi Dorward et al.•ARTICLE•AIDS and Behavior•2024

    We examined the impact of past-year intimate partner violence (IPV) on HIV outcomes among women living with HIV (WLHIV) in Durban, South Africa. We assessed past-year IPV using the WHO Violence Against Women Questionnaire. We conducted logistic regression to assess associations between demographic variables and IPV at baseline, and between IPV at baseline and longitudinal HIV outcomes. Among 235 WLHIV, 17% reported past-year emotional, physical, …

  • The impact of the Covid-19 lockdown on HIV care in 65 South African primary care clinics

    Open Access•Jienchi Dorward, Thokozani Khubone et al.•ARTICLE•The Lancet HIV•2021

    BACKGROUND: The effect of the COVID-19 pandemic on HIV outcomes in low-income and middle-income countries is poorly described. We aimed to measure the impact of the 2020 national COVID-19 lockdown on HIV testing and treatment in KwaZulu-Natal, South Africa, where 1·7 million people are living with HIV. METHODS: In this interrupted time series analysis, we analysed anonymised programmatic data from 65 primary care clinics in KwaZulu-Natal province…

No prominent works on this page.

  • The impact of the Covid-19 lockdown on HIV care in 65 South African primary care clinics

    Open Access•Jienchi Dorward, Thokozani Khubone et al.•ARTICLE•The Lancet HIV•2021

    BACKGROUND: The effect of the COVID-19 pandemic on HIV outcomes in low-income and middle-income countries is poorly described. We aimed to measure the impact of the 2020 national COVID-19 lockdown on HIV testing and treatment in KwaZulu-Natal, South Africa, where 1·7 million people are living with HIV. METHODS: In this interrupted time series analysis, we analysed anonymised programmatic data from 65 primary care clinics in KwaZulu-Natal province…

  • Healthcare worker perspectives on adaptations to differentiated anti-retroviral therapy delivery during Covid-19 in South Africa

    Open Access•Kwena Tlhaku, Lindani Msimango et al.•ARTICLE•PLOS Global Public Health•2024

    During the COVID-19 pandemic, the South African Centralized Chronic Medicines Dispensing and Distribution (CCMDD) programme, adapted to include extended 12-month antiretroviral therapy (ART) prescriptions, 3-months ART refills and earlier eligibility criteria at 6-months after ART initiation. We aimed to explore the experiences of healthcare workers (HCWs) in implementing these adaptations, and to understand the overall impact of COVID-19 on CCMD…

  • Intimate Partner Violence and HIV Outcomes Among Women Living with HIV in Durban, South Africa

    Open Access•Sheila O Ojeaburu, Jienchi Dorward et al.•ARTICLE•AIDS and Behavior•2024

    We examined the impact of past-year intimate partner violence (IPV) on HIV outcomes among women living with HIV (WLHIV) in Durban, South Africa. We assessed past-year IPV using the WHO Violence Against Women Questionnaire. We conducted logistic regression to assess associations between demographic variables and IPV at baseline, and between IPV at baseline and longitudinal HIV outcomes. Among 235 WLHIV, 17% reported past-year emotional, physical, …

  • Impact of increasing CD4 count threshold eligibility for antiretroviral therapy initiation on advanced HIV disease and tuberculosis prevalence and incidence in South Africa

    Open Access•Kwabena Asare, Lara Lewis et al.•ARTICLE•BMJ Global Health•2025

    INTRODUCTION: We investigated the impact of increasing CD4 count eligibility for antiretroviral therapy (ART) initiation on advanced HIV disease (AHD) and tuberculosis (TB) prevalence and incidence among people living with HIV (PLHIV) in South Africa. METHODS: We conducted an interrupted time series analysis with de-identified data of PLHIV aged ≥15 years initiating ART between April 2012 and February 2020 at 65 primary healthcare clinics in KwaZ…

  • Trends in advanced HIV disease, treatment interruption, and viraemia in KwaZulu-Natal, South Africa

    Open Access•Sanele S Mbeje, Lilishia Gounder et al.•ARTICLE•PLOS Global Public Health•2026

    Advanced HIV disease (AHD), treatment interruption and viraemia remain key challenges to effectiveness of HIV programmes in South Africa. Understanding the trends of these measures and their variation across geographic regions can inform more targeted and responsive interventions. We conducted a retrospective cohort study using routine, de-identified data from TIER.Net, a national HIV electronic register. We curated data from 116 primary care cli…

  • Quality assessment of data for decentralised antiretroviral therapy referrals and laboratory results in the South African national electronic HIV management register Tier.Net

    Open Access•Lisanthini Naidu, Johan van der Molen et al.•ARTICLE•PLOS Global Public Health•2026

    Three Interlinked Electronic Register (TIER.Net) is South Africa’s national electronic HIV patient database, used to monitor antiretroviral therapy (ART) delivery and laboratory results. However, few published evaluations have quantified TIER.Net data quality relative to national sources. We aimed to evaluate how well decentralised ART referral and laboratory result data are captured in TIER.Net. We conducted a retrospective analysis comparing TI…

  • Point-of-care HIV viral load testing in a community antiretroviral therapy delivery programme

    Open Access•Jienchi Dorward, Kwena Tlhaku et al.•ARTICLE•PLOS Global Public Health•2026

    Community antiretroviral therapy (ART) delivery programmes allow people with HIV (PWH) to collect treatment nearer to home instead of from clinics. However, delays in laboratory-based viral load (VL) testing can prevent timely community ART prescription renewals. We aimed to determine if clinic point-of-care VL testing could expedite community ART prescription renewals within the Centralised Chronic Medication Dispensing and Distribution programm…

HIV/AIDS Research and Interventions (6 works) · Antiretroviral therapy (5 works) · Medicine (4 works) · Viral load (4 works) · Demography (3 works) · Disease (3 works) · Human immunodeficiency virus (HIV) (3 works) · Psychological intervention (3 works) · Antiretroviral treatment (2 works) · Cohort (2 works)

Ethnos_APP • Open Source Project • MIT License • Frontend v2.0.0 • Privacy and Cookies • API Documentation: api.ethnos.app/docs • API Source Code: GitHub • DOI: 10.5281/zenodo.17049435 • Frontend Source Code: GitHub • DOI: 10.5281/zenodo.17050053 • cruz.rio.br • Expectantes Misericordiae